Navigation Links
Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients

olesterol and those taking lipid lowering agents, have an LDL level that is higher than recommended in national treatment guidelines. Stroke patients with coronary heart disease are at the greatest risk of cardiovascular events yet are the least likely to be at guideline-recommended LDL levels. The authors suggest that future guidelines for lipid management may require additional revision to reflect the results of newer trials such as SPARCL that support the use of statins in stroke patients without coronary heart disease.

About the Overall CARDS Study

The CARDS study, published in The Lancet in 2004, evaluated patients (n=2,838) with type 2 diabetes who did not have existing cardiovascular disease, but had one or more risk factors for it. Lipitor 10 mg significantly reduced the risk of major cardiovascular events by 37 percent and the risk of stroke by 48 percent compared with placebo.

In CARDS, Lipitor was well-tolerated. The overall frequency of adverse events or serious adverse events did not differ between Lipitor and placebo.

About the Overall SPARCL Study

The SPARCL study, published in the New England Journal of Medicine in 2006, is the only study to date evaluating the benefits of a statin solely in patients with a prior stroke or mini-stroke (n=4,731). Lipitor 80 mg reduced the risk of an additional stroke by 16 percent and major coronary events by 35 percent compared with placebo. In a post-hoc analysis of the SPARCL trial, there was a higher incidence of hemorrhagic stroke in patients taking Lipitor 80 mg compared with patients taking placebo. Patients with prior hemorrhagic stroke at study entry appeared to be at an increased risk of hemorrhagic stroke.

In SPARCL, Lipitor was well-tolerated. The rate of side effects such as elevated liver enzymes, muscle weakness or rhabdomyolysis were low and consistent with the known safety profile.

About Lipitor

Lipitor is the most extensively studied and most pr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
2. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
3. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
4. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
5. XTL Provides Update on Phase I Clinical Trial of XTL-2125
6. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
7. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
8. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
9. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
10. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
11. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Post Your Comments:
(Date:5/21/2013)... CINCINNATI , May 21, 2013  LCA-Vision Inc. (NASDAQ: ... correction services under the Lasik Plus ® brand, announces that ... to one-year terms at today,s annual meeting of stockholders.  These ... , co-founder and President of Bahl & Gaynor Investment Counsel ... with BSC Ventures , Edgar F. Heizer ...
(Date:5/21/2013)... , May 21, 2013  Decision Resources, ... advisory firms for pharmaceutical and healthcare issues, ... agent on key efficacy endpoints, including overall ... the most influence over surveyed U.S. and ... (HR-) positive, HER2-negative breast cancer. The two ...
(Date:5/21/2013)... 2013 Hurel Corporation ("Hurel"), a world-leading provider ... platforms, today announced the appointment of James ... Board of Directors. Dr. MacDonald is the former Executive ... Institute ("SPRI"), which was the pharmaceutical development arm of ... Co. in 2009. Over a career that ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... ALCAT Test to help chronic symptoms such as obesity, ... Medical researchers from Dubai today reported in the April ... Medicine (The Effect of The ALCAT Test Diet Therapy ... unable to achieve goal weight loss by calorie restriction ...
... PAUL, Minn., April 3 Torax Medical Inc., a ... of gastroesophageal reflux disease (GERD) has commenced a pivotal ... The trial, which is being conducted at 15 leading ... Europe, will evaluate the safety and effectiveness of the ...
Cached Medicine Technology:Study Confirms: Your Hidden Food Allergies Are Making You Fat 2Study Confirms: Your Hidden Food Allergies Are Making You Fat 3Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment 2
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Medical ... with the prestigious 2013 Top-Rated Award by GreatNonprofits , ... “We are excited to be named a Top-Rated 2013 Nonprofit,” ... without the dedication of our over 3000 Volunteers and Staff ... especially significant as it came from those that have seen ...
(Date:5/21/2013)... Kan. Primary care practice transformation on a ... care reform efforts aimed at achieving better outcomes, ... emerging evidence that transformation toward the patient-centered medical ... health care environment, the U.S. Department of Health ... Quality funded 14 studies to learn more about ...
(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and the ... Community Wellness Fair to educate the public on health initiatives ... on Wednesday, May 22, 2013 from 4:00 pm until 7:00 ... Mallard Creek Road, Charlotte, NC 29262). , Medic, ... Mecklenburg County Department of Social Services are working ...
(Date:5/21/2013)... stent, which is a novel stent platform eluting ... the Xience Prime everolimus-eluting stent for the primary ... nine months in the results of an imaging ... BIOFLOW-II substudy used intravascular ultrasound (IVUS) and optical ... and stent apposition at nine months after treating ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... on cable networks and cable channels across the country, ... on its YouTube channel. The producers of the series ... in the shipping industry, the manufacturing industry, health-related companies, ... medical facilities and medical practitioners in all parts of ...
Breaking Medicine News(10 mins):Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2
... Minimally-Invasive Closed-Chest, Bypass Surgery; Created Robotic ... Emphasize Reproducibility of Procedure and Decrease Learning ... 28 Cardica, Inc.,(Nasdaq: CRDC ) ... M.D., is innovating robot-assisted,minimally-invasive cardiac bypass surgery ...
... May 28 /Xinhua-PRNewswire-FirstCall/ --,China Pharma Holdings, Inc. ... which develops, manufactures, and markets generic and ... it has entered,into a Securities Purchase Agreement ... accredited investors ("Investors") pursuant to which,China Pharma ...
... virus out of reach of drugs , , WEDNESDAY, May ... type of cell provides a "hideout" for HIV during drug ... These follicular dendritic cells (FDCs) are located throughout the body ... Brigham Young University and Johns Hopkins School of Medicine. , ...
... Fla., May 28 The Quantum Group,Inc. (Amex: ... of,business process solutions, service chain management, strategic consulting,and ... today that it is joining IBM,s Latin American ... a collection of human and computing,resources in North ...
... May 28 /PRNewswire-FirstCall/ - Innolife Pharma, Inc.,(Other OTC:INNP.PK ... to announce that,they have unveiled their new website. ... a much more comfortable feeling with regards to ... endeavors., About Innolife Pharma Inc., --------------------------, ...
... Response TV Leader Guthy-Renker Attracts yet Another Celebrity for ... America,s Best-Selling ... Guthy-Renker announced,today that Ryan Sheckler, famed skateboarder and television ... best-selling acne treatment,Proactiv Solution. Known for its wide range ...
Cached Medicine News:Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 2Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 3Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 4Health News:China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million 2Health News:China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million 3Health News:Scientists Break Into HIV 'Hideout' 2Health News:The Quantum Group & IBM Sign Research Collaboration Agreement for the LA Grid University Consortium 2Health News:The Quantum Group & IBM Sign Research Collaboration Agreement for the LA Grid University Consortium 3Health News:The Quantum Group & IBM Sign Research Collaboration Agreement for the LA Grid University Consortium 4Health News:Professional Skateboarder Ryan Sheckler to Become the Newest Face of Proactiv Solution 2Health News:Professional Skateboarder Ryan Sheckler to Become the Newest Face of Proactiv Solution 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: